Effects of apolipoprotein E genotype on serum lipids in obstructive sleep apnoea.
There is increasing evidence that intermittent hypoxia resulting from obstructive sleep apnoea (OSA) is independently associated with dyslipidaemia. Currently, no data exist on potential links between OSA-related dyslipidaemia and susceptibility genes for dyslipidaemia in such patients. Our aim was to study the effects of the apolipoprotein E (APOE) genotype and sleep apnoea severity on atherogenic dyslipidaemia in patients with OSA. 519 clinically stable subjects prospectively recruited at a tertiary referral teaching hospital underwent full polysomnography. APOE gene polymorphisms were assessed using real-time PCR. In all APOE genotype groups, serum triglycerides increased while high-density lipoprotein (HDL) cholesterol was reduced with increasing severity of OSA in each APOE genotype group, whereas the deleterious effects of OSA on serum apolipoprotein (Apo)B levels were observed in ε2 carriers and the ε3/ε3 genotype only. Nevertheless, the ε4 allele carriers had ApoB levels within the risk range, irrespective of nocturnal hypoxia. In addition, among patients with the high-risk ε4 genotype, those with the most severe nocturnal hypoxia had significantly higher triglyceride and lower HDL cholesterol levels compared with nonhypoxic ε4 subjects. APOE genotype and the oxygen desaturation index were both independent predictors of serum triglyceride levels (p=0.009 and p<0.001, respectively; R(2)=0.148) and ApoB levels (p=0.001 and p=0.003, respectively; R(2)=0.104). Our findings suggest that OSA has adverse effects on several lipid parameters over and above the effects carried by APOE genotype. Further st1udies are needed to analyse the effects of high-risk genotypes on metabolic and cardiovascular outcomes in patients with OSA.
Faculty of Medicine, P.J. Šafárik University, Košice.
Radovan
R
Tisko
Zuzana
Z
Sopkova
Viera
V
Habalova
Zuzana
Z
Dorkova
Eva
E
Slaba
Martin
M
Javorsky
Ivan
I
Tkac
Renata L
RL
Riha
Ruzena
R
Tkacova
D000328:Adult; D000483:Alleles; D001057:Apolipoproteins E / Q000235:genetics*; D050171:Dyslipidemias / Q000097:blood* / Q000150:complications / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006579:Heterozygote; D006801:Humans; D000860:Hypoxia; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010100:Oxygen / Q000737:chemistry; D011110:Polymorphism, Genetic; D017286:Polysomnography; D011446:Prospective Studies; D060888:Real-Time Polymerase Chain Reaction; D012307:Risk Factors; D012890:Sleep; D020181:Sleep Apnea, Obstructive / Q000097:blood* / Q000150:complications / Q000235:genetics*; D062606:Tertiary Care Centers; D014280:Triglycerides / Q000097:blood
D001057:Apolipoproteins E; D008055:Lipids; D014280:Triglycerides; D010100:Oxygen